Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patientsIn large clinical trial conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for ventilation. With large numbers of COVID-19 patients requiring hospitalization, these outcomes could also help reduce the overload on intensive care units around the world. Whether providing increased doses of blood thinners routinely administered to hospitalized patients would be safe and effective was unknown at that time. Moderately ill patients are those not in intensive care and who did not receive organ support such as mechanical ventilation at trial enrollment. However, research questions remain about how to further improve the clinical care of COVID-19 patients.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.